Page last updated: 2024-08-22

trimetazidine and Coronary Stenosis

trimetazidine has been researched along with Coronary Stenosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ambesh, P; Garg, N; Goel, PK; Kapoor, A; Kashyap, S; Kazmi, DH; Khanna, R; Kumar, S; Sinha, A; Tewari, S	1
Dec, I; Poloński, L; Wilczek, K; Wojnar, R	1

Trials

1 trial(s) available for trimetazidine and Coronary Stenosis

Article	Year
Trimetazidine limits the effects of myocardial ischaemia during percutaneous coronary angioplasty. Current medical research and opinion, 2002, Volume: 18, Issue:7 Topics: Angioplasty, Balloon, Coronary; Chi-Square Distribution; Coronary Stenosis; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Stents; Treatment Outcome; Trimetazidine; Vasodilator Agents	2002

Other Studies

1 other study(ies) available for trimetazidine and Coronary Stenosis

Article	Year
Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury. Indian heart journal, 2018, Volume: 70 Suppl 3 Topics: Biomarkers; Coronary Angiography; Coronary Stenosis; Creatine Kinase, MB Form; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Postoperative Complications; Prognosis; Trimetazidine; Troponin I; Vasodilator Agents	2018

Article

Year

Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.

Indian heart journal, 2018, Volume: 70 Suppl 3

Topics: Biomarkers; Coronary Angiography; Coronary Stenosis; Creatine Kinase, MB Form; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Postoperative Complications; Prognosis; Trimetazidine; Troponin I; Vasodilator Agents

2018